However, this inhibitive effect was significantly affected by lymph node metastasis (P = 0.001), that is, the similar expression of PKM2 in primary breast carcinoma tissues with and without evidence of recurrent metastasis might be attributed to the similar lymph node metastasis between the two groups. Here, PKM is linked to metastatic malignant neoplasm in the lymph nodes.